Ariad's cancer drug trials placed on partial hold, shares slump
(Reuters) - Ariad Pharmaceuticals Inc said the U.S. Food and Drug Administration had placed a partial hold on patient enrollment for trials of its can...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/S-32v8icnDU/story01.htm
No comments:
Post a Comment